?
Reinseth Theresa E
Sr Vice President & CAO
3M Company
US, Saint Paul [HQ]
CIK
1772245
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
43,880,524
Price per Share :
$141.63
Equivalence :
$6,214,798,614.12
Transaction History
-
S43,880,524 Shares After TransactionValue : $5,603,981,720.04Sold $131,924.43Transaction Date : 11/20/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
A25,903,584 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/05/24
-
Footnotes
-
-
Footnotes:#1 Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2021. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified.#2 Includes shares acquired pursuant to 3M's Dividend Reinvestment Plan.#3 The number of shares withheld for taxes was estimated and will be revised by amendment if necessary.
-
F24,193,584 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/05/24
-
Footnotes
-
-
Footnotes:#1 Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2021. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified.#2 Includes shares acquired pursuant to 3M's Dividend Reinvestment Plan.#3 The number of shares withheld for taxes was estimated and will be revised by amendment if necessary.
-
M62,870,524 Shares After TransactionValue : $7,998,388,063.28$241,590.78Transaction Date : 11/01/24
-
Footnotes
-
-
Footnotes:#1 The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024.
-
F54,210,524 Shares After TransactionValue : $6,896,662,863.28$110,172.52Transaction Date : 11/01/24
-
Footnotes
-
-
Footnotes:#1 The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024.